109 related articles for article (PubMed ID: 12880494)
1. Tenofovir poses risk with didanosine.
AIDS Patient Care STDS; 2003 Jun; 17(6):309. PubMed ID: 12880494
[No Abstract] [Full Text] [Related]
2. Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults.
Martínez E; Milinkovic A; de Lazzari E; Ravasi G; Blanco JL; Larrousse M; Mallolas J; García F; Miró JM; Gatell JM
Lancet; 2004 Jul 3-9; 364(9428):65-7. PubMed ID: 15234858
[TBL] [Abstract][Full Text] [Related]
3. Unexpected drug interactions and adverse events with antiretroviral drugs.
Moyle G; Boffito M
Lancet; 2004 Jul 3-9; 364(9428):8-10. PubMed ID: 15234836
[No Abstract] [Full Text] [Related]
4. Tenofovir-related nephrotoxicity in HIV-infected patients.
Barrios A; García-Benayas T; González-Lahoz J; Soriano V
AIDS; 2004 Apr; 18(6):960-3. PubMed ID: 15060449
[No Abstract] [Full Text] [Related]
5. Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
Blanchard JN; Wohlfeiler M; Canas A; King K; Lonergan JT
Clin Infect Dis; 2003 Sep; 37(5):e57-62. PubMed ID: 12942419
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
7. Pancreatitis in an HIV-infected person on a tenofovir, didanosine and stavudine containing highly active antiretroviral treatment.
Callens S; De Schacht C; Huyst V; Colebunders R
J Infect; 2003 Aug; 47(2):188-9. PubMed ID: 12860159
[No Abstract] [Full Text] [Related]
8. Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine?
Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
J Acquir Immune Defic Syndr; 2004 Apr; 35(4):427-8. PubMed ID: 15097160
[No Abstract] [Full Text] [Related]
9. Severe toxicity associated with the combination of tenofovir and didanosine: case report and review.
Masiá M; Gutiérrez F; Padilla S; Ramos JM; Pascual J
Int J STD AIDS; 2005 Sep; 16(9):646-8. PubMed ID: 16176639
[TBL] [Abstract][Full Text] [Related]
10. Drug points: Fatal lactic acidosis associated with tenofovir.
Rivas P; Polo J; de Górgolas M; Fernández-Guerrero ML
BMJ; 2003 Sep; 327(7417):711. PubMed ID: 14512477
[No Abstract] [Full Text] [Related]
11. Warning issued on non-response rates.
AIDS Patient Care STDS; 2003 Oct; 17(10):539. PubMed ID: 14588094
[No Abstract] [Full Text] [Related]
12. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
13. Renal lesions in HIV-1-positive patient treated with tenofovir.
Créput C; Gonzalez-Canali G; Hill G; Piketty C; Kazatchkine M; Nochy D
AIDS; 2003 Apr; 17(6):935-7. PubMed ID: 12660548
[No Abstract] [Full Text] [Related]
14. [Lipid profile and body fat--significant "side effect" of antiretroviral therapy. Tenofovir: favorable profile of adverse effects].
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():83. PubMed ID: 15011603
[No Abstract] [Full Text] [Related]
15. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
16. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
17. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
[No Abstract] [Full Text] [Related]
18. Fanconi syndrome and acute renal failure in a patient treated with tenofovir: a call for caution.
Gaspar G; Monereo A; García-Reyne A; de Guzmán M
AIDS; 2004 Jan; 18(2):351-2. PubMed ID: 15075563
[No Abstract] [Full Text] [Related]
19. Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir.
Callens S; De Roo A; Colebunders R
J Infect; 2003 Oct; 47(3):262-3. PubMed ID: 12963392
[No Abstract] [Full Text] [Related]
20. Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosine.
Murphy MD; O'Hearn M; Chou S
Clin Infect Dis; 2003 Apr; 36(8):1082-5. PubMed ID: 12684925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
